Reason: Superpotent Drug: Out of Specification (OOS) results observed for unit dose content.
Distributed: USA nationwide.Reason: Failed dissolution specification: Out of specification results observed in 24-month long term stability testing.
Distributed: Nationwide in the USAReason: Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).
Distributed: Nationwide in the USReason: CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.
Distributed: Product was distributed to two distributors who further distributed Nationwide in the USA.Reason: Non-Sterility: FDA analysis found unopened products to have bacterial contamination.
Distributed: Product was distributed to two distributors who further distributed Nationwide in the USA.Reason: CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.
Distributed: Product was distributed to two distributors who further distributed Nationwide in the USA.Reason: Non-Sterility: FDA analysis found unopened products to have bacterial contamination.
Distributed: Product was distributed to two distributors who further distributed Nationwide in the USA.Reason: Presence of Particulate Matter: Particulate matter identified as fiber.
Distributed: Nationwide within the United StatesReason: Presence of Particulate Matter: Particulate matter identified as fiber.
Distributed: Nationwide within the United StatesReason: Lack of assurance of sterility: bags have the potential to leak.
Distributed: USA Nationwide